DT-168 is a GeneTAC® small molecule, formulated as an eye drop, that is designed to selectively target the CTG repeat expansion in the TCF4 gene and reduce the expression of the mutant gene product ...

In this expert perspective, Manjot K. Gill, MD, discusses faricimab for the management of retinal vein occlusion. In this expert perspective, Manjot K. Gill, MD, discusses the potential FDA ...

A detached retina occurs when the retina, a layer of tissue that covers most of the back of the eye, separates from its anchored position. Eye trauma is the most common cause, and the symptoms—blurred ...